Literature DB >> 15249704

Clinical characteristics of eight patients with congenital nephrogenic diabetes insipidus.

Haruo Mizuno1, Yukari Sugiyama, Yoichiro Ohro, Hiroki Imamine, Masanori Kobayashi, Sei Sasaki, Sinichi Uchida, Hajime Togari.   

Abstract

Congenital nephrogenic diabetes insipidus (NDI) is characterized by the insensitivity of the distal nephron to arginine vasopressin. Clinical knowledge of this disease is based largely on case reports. For this study, we investigated the clinical findings of eight patients in terms of age at onset, age at diagnosis, main complaint, results of physical examination, the diagnosis, the effect of treatment, kidney function, and presence or absence of gene defects. The main complaints of all eight cases at initial examination were unknown fever, failure to thrive, and short stature. Polyuria and polydipsia are not always the chief complaints with congenital NDI. In one case, diabetes insipidus could be diagnosed based only on the results of a 5% hypertonic saline test. In six cases, we found abnormalities in the V2 receptor gene. Initially, trichlormethiazide therapy was shown to have a significant effect on polyuria; however, this effect decreased over time. In one patient with partial NDI, the addition of trichlormethiazide twice a day to 1-desamino-8-D-arginine vasopressin increased urine osmolality in the morning and caused nocturia to disappear. Results of 99mTc-diethylenetriamine pentaacetic acid kidney scintigraphy revealed a slight decrease in glomerular filtration rate in three patients. No patient experienced serious renal dysfunction. Copyright 2004 Humana Press Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15249704     DOI: 10.1385/ENDO:24:1:055

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  17 in total

1.  Report of 33 novel AVPR2 mutations and analysis of 117 families with X-linked nephrogenic diabetes insipidus.

Authors:  Marie-Françoise Arthus; Michèle Lonergan; M Joyce Crumley; Anna K Naumova; Denis Morin; Luiz A DE Marco; Bernard S Kaplan; Gary L Robertson; Sei Sasaki; Kenneth Morgan; Daniel G Bichet; T Mary Fujiwara
Journal:  J Am Soc Nephrol       Date:  2000-06       Impact factor: 10.121

2.  Nephrogenic diabetes insipidus and obstructive uropathy.

Authors:  J Wiggelinkhuizen; P J Retief; B Wolff; R M Fisher; B J Cremin
Journal:  Am J Dis Child       Date:  1973-09

3.  Progressive hydronephrosis, hydroureter, and dilatation of the bladder in siblings with congenital nephrogenic diabetes insipidus.

Authors:  R W Ten Bensel; E R Peters
Journal:  J Pediatr       Date:  1970-09       Impact factor: 4.406

4.  X-linked nephrogenic diabetes insipidus mutations in North America and the Hopewell hypothesis.

Authors:  D G Bichet; M F Arthus; M Lonergan; G N Hendy; A J Paradis; T M Fujiwara; K Morgan; M C Gregory; W Rosenthal; A Didwania
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

5.  Clinical presentation and follow-up of 30 patients with congenital nephrogenic diabetes insipidus.

Authors:  A F van Lieburg; N V Knoers; L A Monnens
Journal:  J Am Soc Nephrol       Date:  1999-09       Impact factor: 10.121

6.  Nature and recurrence of AVPR2 mutations in X-linked nephrogenic diabetes insipidus.

Authors:  D G Bichet; M Birnbaumer; M Lonergan; M F Arthus; W Rosenthal; P Goodyer; H Nivet; S Benoit; P Giampietro; S Simonetti
Journal:  Am J Hum Genet       Date:  1994-08       Impact factor: 11.025

7.  Successful treatment of partial nephrogenic diabetes insipidus with thiazide and desmopressin.

Authors:  Haruo Mizuno; Shinji Fujimoto; Yukari Sugiyama; Masanori Kobayashi; Yoichiro Ohro; Shinichi Uchida; Sei Sasaki; Hajime Togari
Journal:  Horm Res       Date:  2003

8.  Requirement of human renal water channel aquaporin-2 for vasopressin-dependent concentration of urine.

Authors:  P M Deen; M A Verdijk; N V Knoers; B Wieringa; L A Monnens; C H van Os; B A van Oost
Journal:  Science       Date:  1994-04-01       Impact factor: 47.728

9.  Inheritance of mutations in the V2 receptor gene in thirteen families with nephrogenic diabetes insipidus.

Authors:  N V Knoers; A M van den Ouweland; M Verdijk; L A Monnens; B A van Oost
Journal:  Kidney Int       Date:  1994-07       Impact factor: 10.612

10.  Patients with autosomal nephrogenic diabetes insipidus homozygous for mutations in the aquaporin 2 water-channel gene.

Authors:  A F van Lieburg; M A Verdijk; V V Knoers; A J van Essen; W Proesmans; R Mallmann; L A Monnens; B A van Oost; C H van Os; P M Deen
Journal:  Am J Hum Genet       Date:  1994-10       Impact factor: 11.025

View more
  9 in total

1.  Clinical and molecular analysis of a Chinese family with autosomal dominant neurohypophyseal diabetes insipidus associated with a novel missense mutation in the vasopressin-neurophysin II gene.

Authors:  Yongfeng Luo; Binbin Wang; Yu Qiu; Chuan Zhang; Chengluo Jin; Yakun Zhao; Qingguo Zhu; Xu Ma
Journal:  Endocrine       Date:  2012-02-04       Impact factor: 3.633

2.  Mutations in the AVPR2, AVP-NPII, and AQP2 genes in Turkish patients with diabetes insipidus.

Authors:  Duygu Duzenli; Emel Saglar; Ferhat Deniz; Omer Azal; Beril Erdem; Hatice Mergen
Journal:  Endocrine       Date:  2012-05-29       Impact factor: 3.633

Review 3.  Familial forms of diabetes insipidus: clinical and molecular characteristics.

Authors:  Muriel Babey; Peter Kopp; Gary L Robertson
Journal:  Nat Rev Endocrinol       Date:  2011-07-05       Impact factor: 43.330

4.  Hypertensive urgency in nephrogenic diabetes insipidus with concomitant Hinman syndrome.

Authors:  Yu Guang Tan; Daniel Wei Keong Chan; Fabian Kok Peng Yap; Te-Lu Yap
Journal:  BMJ Case Rep       Date:  2019-07-27

5.  Clinical overview of nephrogenic diabetes insipidus based on a nationwide survey in Japan.

Authors:  Masanobu Fujimoto; Shin-Ichi Okada; Yuki Kawashima; Rei Nishimura; Naoki Miyahara; Yasuo Kawaba; Keiichi Hanaki; Eiji Nanba; Yoshiaki Kondo; Takashi Igarashi; Susumu Kanzaki
Journal:  Yonago Acta Med       Date:  2014-07-30       Impact factor: 1.641

6.  Hereditary nephrogenic diabetes insipidus in Japanese patients: analysis of 78 families and report of 22 new mutations in AVPR2 and AQP2.

Authors:  Sei Sasaki; Motoko Chiga; Eriko Kikuchi; Tatemitsu Rai; Shinichi Uchida
Journal:  Clin Exp Nephrol       Date:  2012-11-14       Impact factor: 2.801

7.  Nephrogenic diabetes insipidus: treat with caution.

Authors:  Thierry Boussemart; Jacqueline Nsota; Dominique Martin-Coignard; Gérard Champion
Journal:  Pediatr Nephrol       Date:  2009-04-17       Impact factor: 3.714

Review 8.  Nephrogenic diabetes insipidus: essential insights into the molecular background and potential therapies for treatment.

Authors:  Hanne B Moeller; Søren Rittig; Robert A Fenton
Journal:  Endocr Rev       Date:  2013-01-29       Impact factor: 19.871

9.  Growth failure in an infant with congenital nephrogenic diabetes insipidus during sodium restriction.

Authors:  Goro Sasaki; Tomohiro Ishii; Naoko Amano; Rumi Hachiya; Satoshi Narumi; Tomonobu Hasegawa
Journal:  Clin Pediatr Endocrinol       Date:  2007-11-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.